Model informed quantification of the feed-forward stimulation of growth hormone by growth hormone-releasing hormone

被引:1
作者
Esdonk, Michiel J. [1 ,2 ]
Burggraaf, Jacobus [1 ,2 ]
van der Graaf, Piet H. [1 ,3 ]
Stevens, Jasper [4 ]
机构
[1] Leiden Univ, Leiden Acad Ctr Drug Res, Div Syst Biomed & Pharmacol, Leiden, Netherlands
[2] Ctr Human Drug Res, Leiden, Netherlands
[3] Certara QSP, Canterbury, Kent, England
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
关键词
GH; Growth hormone; growth hormone-releasing hormone; kinetics; NLME model; stimulation test; BODY-FAT DISTRIBUTION; SECRETION; PLASMA; SOMATOSTATIN; CONSTRUCT; VOLUME; AXIS;
D O I
10.1111/bcp.14265
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims Growth hormone (GH) secretion is pulsatile and secretion varies highly between individuals. To understand and ultimately predict GH secretion, it is important to first delineate and quantify the interaction and variability in the biological processes underlying stimulated GH secretion. This study reports on the development of a population nonlinear mixed effects model for GH stimulation, incorporating individual GH kinetics and the stimulation of GH by GH-releasing hormone (GHRH). Methods Literature data on the systemic circulation, the median eminence, and the anterior pituitary were included as system parameters in the model. Population parameters were estimated on data from 8 healthy normal weight and 16 obese women who received a 33 mu g recombinant human GH dose. The next day, a bolus injection of 100 mu g GHRH was given to stimulate GH secretion. Results The GH kinetics were best described with the addition of 2 distribution compartments with a bodyweight dependent clearance (increasing linearly from 24.7 L/h for a 60-kg subject to 32.1 L/h for a 100-kg subject). The model described the data adequately with high parameter precision and significant interindividual variability on the GH clearance and distribution volume. Additionally, high variability in the amount of secreted GH, driven by GHRH receptor activation, was identified (coefficient of variation = 90%). Conclusion The stimulation of GH by GHRH was quantified and significant interindividual variability was identified on multiple parameters. This model sets the stage for further development of by inclusion of additional physiological components to quantify GH secretion in humans.
引用
收藏
页码:1575 / 1584
页数:10
相关论文
共 50 条
  • [21] PROLACTIN AND GROWTH-HORMONE RESPONSES TO GROWTH HORMONE-RELEASING HORMONE IN ACUTE SCHIZOPHRENIA
    NEROZZI, D
    MAGNANI, A
    SFORZA, V
    SCARAMUCCI, E
    CERILLI, M
    MORETTI, C
    ANTONOZZI, I
    FRAJESE, G
    NEUROPSYCHOBIOLOGY, 1990, 23 (01) : 15 - 17
  • [22] Testing for growth hormone deficiency in adults: doing without growth hormone-releasing hormone
    Kargi, Atil Y.
    Merriam, George R.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2012, 19 (04) : 300 - 305
  • [23] STIMULATION AND INHIBITION OF GROWTH-HORMONE SECRETION BY INTERLEUKIN-1-BETA - THE INVOLVEMENT OF GROWTH HORMONE-RELEASING HORMONE
    PAYNE, LC
    OBAL, F
    OPP, MR
    KRUEGER, JM
    NEUROENDOCRINOLOGY, 1992, 56 (01) : 118 - 123
  • [24] Growth hormone-releasing hormone: Past and present
    Sassolas, G
    HORMONE RESEARCH, 2000, 53 : 88 - 92
  • [25] Combined growth hormone-releasing hormone and growth hormone-releasing peptide-6 test for the evaluation of growth hormone secretion in children with growth hormone deficiency and growth hormone neurosecretory dysfunction
    Spiliotis, Bessie E.
    Papadimitriou, Dimitrios T.
    Alexandrides, Theodore K.
    Karystianos, Christoforos
    Nikiforidis, George
    Vassilakos, Pavlos
    Beratis, Nicholas G.
    Casanueva, Felipe F.
    HORMONE RESEARCH, 2008, 70 (04) : 215 - 223
  • [26] Growth Hormone-Releasing Hormone in Endothelial Inflammation
    Barabutis, Nektarios
    Akhter, Mohammad S.
    Kubra, Khadeja-Tul
    Jackson, Keith
    ENDOCRINOLOGY, 2022, 164 (02)
  • [27] Outcome of growth hormone therapy in children with growth hormone deficiency showing an inadequate response to growth hormone-releasing hormone
    Saenger, P
    Pescovitz, OH
    Bercu, BB
    Murray, FT
    Landy, H
    Brentzel, J
    O'Dea, L
    Hanson, B
    Howard, C
    Reiter, EO
    ENDOCRINE, 2001, 15 (01) : 51 - 56
  • [28] Outcome of growth hormone therapy in children with growth hormone deficiency showing an inadequate response to growth hormone-releasing hormone
    Paul Saenger
    Ora H. Pescovitz
    Barry B. Bercu
    Frederick T. Murray
    Hal Landy
    Jim Brentzel
    Louis O'Dea
    B. Hanson
    Campbell Howard
    Edward O. Reiter
    Endocrine, 2001, 15 : 51 - 56
  • [29] THYROTROPIN-RELEASING-HORMONE INCREASES SERUM LEVELS OF GROWTH HORMONE-RELEASING HORMONE AND GROWTH-HORMONE IN PATIENTS WITH ACROMEGALY
    HULTING, AL
    THEODORSSON, E
    WERNER, S
    JOURNAL OF INTERNAL MEDICINE, 1992, 232 (03) : 229 - 235
  • [30] GROWTH HORMONE-RELEASING HORMONE AND SOMATOSTATIN IN NORMAL AND TUMORAL HUMAN PITUITARIES
    BENLOT, C
    PAGESY, P
    PEILLON, F
    JOUBERTBRESSION, D
    PEPTIDES, 1991, 12 (05) : 945 - 950